NCT06939634View on ClinicalTrials.gov

Evaluation of Usability and Safety of the System Atalante in Patients With High Paraplegia and Tetraplegia

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

September 1, 2024

Study Completion Date

September 1, 2024

Conditions
Spinal Cord InjuryTetraplegia/TetraparesisParaplegia, CompleteParaplegia, IncompleteGuillain Barré Syndrome
Interventions
DEVICE

Hands-free exoskeleton

Having undergone at least on session with Atalante exoskeleton. Clinical, safety and session data are collected retrospectively.

Trial Locations (3)

27180

Hôpital La Musse, Saint-Sébastien-de-Morsent

62600

Fondation Hopale, Berck

63330

CMPR de Pionsat, Pionsat

All Listed Sponsors
lead

Wandercraft

INDUSTRY

NCT06939634 - Evaluation of Usability and Safety of the System Atalante in Patients With High Paraplegia and Tetraplegia | Biotech Hunter | Biotech Hunter